News | Artificial Intelligence | December 13, 2022

The secure nationwide AI-powered cloud platform streamlines care team communication and delivers patient-specific imaging insights within clinical workflows

The secure nationwide AI-powered cloud platform streamlines care team communication and delivers patient-specific imaging insights within clinical workflows

December 13, 2022 — Densitas Inc., a global provider of AI solutions for digital mammography and breast screening, today announced that it has connected to the Nuance Precision Imaging Network (PIN), a secure nationwide cloud platform empowering collaborative care teams with streamlined communications and workflow-integrated AI insights from diagnostic imaging to improve healthcare outcomes and costs. 

Densitas intelliMammo, comprising intelliMammo densityAI, qualityAI, and riskAI, offers a FDA/ACR compliant solution for clinical and enterprise decision-making that includes breast density, breast cancer risk, and clinical image quality. IntelliMammo presents clinical care teams with on-demand actionable information and digitized workflows to systematically improve mammography quality, organizational and workflow efficiencies, and support early breast cancer detection and treatment. 

Leveraging the nationwide scale of the Nuance PowerScribe and Nuance PowerShare diagnostic imaging solutions, the Nuance Precision Imaging Network connects radiologists, providers, health plans, self-insured employers, life science companies, and other imaging stakeholders to broaden access to precision diagnostics and therapeutics, increase healthcare efficiency, and lower costs. It enables secure and seamless sharing of AI insights from diagnostic imaging to enhance clinical decision-making, enhance care team collaboration, and facilitate the earlier detection and treatment of diseases for improved patient outcomes. 

"Our intelliMammo platform provides a solid foundation for population health management as patients navigate through breast cancer screening, diagnostic, treatment, and prevention pathways," said Mo Abdolell, CEO, of Densitas. "Through the Nuance Precision Imaging Network, intelliMammo becomes immediately accessible to over 10,000 healthcare facilities across the US. The addition of intelliMammo opens the door to Nuance customers to capture information from routine screening mammograms and seamlessly leverage patient-centered data and insights in their existing clinical and administrative workflows." 

"We're proud to support Densitas with seamless workflow-integrated access through the Nuance Precision Imaging Network, providing powerful clinical decision support tools at the point-of-care as they advance their important work in breast cancer screening," said Roland Dias, Vice President, Precision Imaging Network, Nuance. 

For more information: www.densitas.com 

 

Find more RSNA22 coverage here 


Related Content

News | Prostate Cancer

July 9, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time July 09, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

July 2, 2025 — Philips has received FDA 510(k) clearance for SmartSpeed Precise[1] MR’s latest deep learning ...

Time July 03, 2025
arrow
News | Ultrasound Imaging

July 1, 2025 — UPDATE: The final paper is now available at: JMIR AI - ChatGPT-4–Driven Liver Ultrasound Radiomics ...

Time July 01, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

June 26, 2025 — Siemens Healthineers has received Food and Drug Administration clearance for the Magnetom Flow.Ace, its ...

Time June 26, 2025
arrow
News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | Women's Health

June 23, 2025 — Susan G. Komen, the world’s leading breast cancer organization, recently announced it is awarding $10.8 ...

Time June 23, 2025
arrow
News | Bone Densitometry Systems

June 19, 2025 — Naitive Technologies has published results demonstrating the diagnostic performance of its AI-powered ...

Time June 18, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
Feature | Women's Health | Christine Murray

In breast cancer detection, speed and accuracy are more than clinical goals – they can significantly increase chances ...

Time June 17, 2025
arrow
News | Digital Pathology

June 11, 2025 — Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to ...

Time June 12, 2025
arrow
Subscribe Now